1 |
SIEGEL R L, MILLER K D, GODING SAUER A, et al. Colorectal cancer statistics, 2020[J]. CA Cancer J Clin, 2020, 70(3): 145-164.
|
2 |
HARUKI K, KOSUMI K, HAMADA T, et al. Association of autophagy status with amount of Fusobacterium nucleatum in colorectal cancer[J]. J Pathol, 2020, 250(4): 397-408.
|
3 |
YU T, GUO F F, YU Y N, et al. Fusobacterium nucleatum promotes chemoresistance to colorectal cancer by modulating autophagy[J]. Cell, 2017, 170(3): 548-563.e16.
|
4 |
MIMA K, NISHIHARA R, QIAN Z R, et al. Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis[J]. Gut, 2016, 65(12): 1973-1980.
|
5 |
VUJOVIC M, DEGN K F, MARIN F I, et al. T cell receptor sequence clustering and antigen specificity[J]. Comput Struct Biotechnol J, 2020, 18: 2166-2173.
|
6 |
CHEN M, CHEN R Z, JIN Y, et al. Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer[J]. Nat Commun, 2021, 12(1): 6655.
|
7 |
SIMNICA D, AKYÜZ N, SCHLIFFKE S, et al. T cell receptor next-generation sequencing reveals cancer-associated repertoire metrics and reconstitution after chemotherapy in patients with hematological and solid tumors[J]. Oncoimmunology, 2019, 8(11): e1644110.
|
8 |
SONG L, COHEN D, OUYANG Z Y, et al. TRUST4: immune repertoire reconstruction from bulk and single-cell RNA-seq data[J]. Nat Methods, 2021, 18(6): 627-630.
|
9 |
SHAO H W, LIN Y M, WANG T, et al. Identification of peptide-specific TCR genes by in vitro peptide stimulation and CDR3 length polymorphism analysis[J]. Cancer Lett, 2015, 363(1): 83-91.
|
10 |
LOONEY T J, TOPACIO-HALL D, LOWMAN G, et al. TCR convergence in individuals treated with immune checkpoint inhibition for cancer[J]. Front Immunol, 2020, 10: 2985.
|
11 |
STEWART J J, LEE C Y, IBRAHIM S, et al. A Shannon entropy analysis of immunoglobulin and T cell receptor[J]. Mol Immunol, 1997, 34(15): 1067-1082.
|
12 |
HOPKINS A C, YARCHOAN M, DURHAM J N, et al. T cell receptor repertoire features associated with survival in immunotherapy-treated pancreatic ductal adenocarcinoma[J]. JCI Insight, 2018, 3(13): e122092.
|
13 |
HAN J F, DUAN J C, BAI H, et al. TCR repertoire diversity of peripheral PD-1+ CD8+ T cells predicts clinical outcomes after immunotherapy in patients with non-small cell lung cancer[J]. Cancer Immunol Res, 2020, 8(1): 146-154.
|
14 |
JOSHI K, MILIGHETTI M, CHAIN B M. Application of T cell receptor (TCR) repertoire analysis for the advancement of cancer immunotherapy[J]. Curr Opin Immunol, 2022, 74: 1-8.
|
15 |
AMIN M B, GREENE F L, EDGE S B, et al. The Eighth Edition AJCC Cancer Staging Manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging[J]. CA Cancer J Clin, 2017, 67(2): 93-99.
|
16 |
BUHLER S, BETTENS F, DANTIN C, et al. Genetic T-cell receptor diversity at 1 year following allogeneic hematopoietic stem cell transplantation[J]. Leukemia, 2020, 34(5): 1422-1432.
|
17 |
FARMANBAR A, KNELLER R, FIROUZI S. RNA sequencing identifies clonal structure of T-cell repertoires in patients with adult T-cell leukemia/lymphoma[J]. NPJ Genom Med, 2019, 4: 10.
|
18 |
CHARLES J, MOURET S, CHALLENDE I, et al. T-cell receptor diversity as a prognostic biomarker in melanoma patients[J]. Pigment Cell Melanoma Res, 2020, 33(4): 612-624.
|
19 |
SHERWOOD A M, EMERSON R O, SCHERER D, et al. Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue[J]. Cancer Immunol Immunother, 2013, 62(9): 1453-1461.
|